Literature DB >> 22239565

The ultra high risk approach to define psychosis risk.

Alison R Yung1, Paolo Fusar-Poli, Barnaby Nelson.   

Abstract

Although prodromal symptoms of psychosis have long been recognized, the clinical management of psychotic disorders conventionally begins at the first episode of frank psychosis, and, until recently, the period immediately preceding the first episode received relatively little attention. Over the last fifteen years, there has been increasing academic and clinical interest in people presenting with potentially prodromal symptoms. This clinical syndrome has been termed an "At Risk Mental State", and operationalised criteria, the "Ultra High Risk (UHR)", or "Clinical High Risk" criteria, have been developed to identify the syndrome. We will review here the mainstreams of the UHR paradigms focusing on the conceptual basis, potentials and limitations in current psychiatric research.

Entities:  

Mesh:

Year:  2012        PMID: 22239565     DOI: 10.2174/138161212799316299

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

Review 1.  Multimodal functional and structural imaging investigations in psychosis research.

Authors:  C Christoph Schultz; Paolo Fusar-Poli; Gerd Wagner; Kathrin Koch; Claudia Schachtzabel; Oliver Gruber; Heinrich Sauer; Ralf G M Schlösser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-02       Impact factor: 5.270

2.  Tinnitus: a potential confound when assessing perceptual abnormalities in ultra-high risk youth.

Authors:  Derek J Dean; Vijay A Mittal
Journal:  Schizophr Res       Date:  2013-05-18       Impact factor: 4.939

3.  Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.

Authors:  Gregor E Berger; Stefan Smesny; Miriam R Schäfer; Berko Milleit; Kerstin Langbein; Uta-Christina Hipler; Christine Milleit; Claudia M Klier; Monika Schlögelhofer; Magdalena Holub; Ingrid Holzer; Michael Berk; Patrick D McGorry; Heinrich Sauer; G Paul Amminger
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

4.  Clinical profile and conversion rate to full psychosis in a prospective cohort study of youth affected by autism spectrum disorder and attenuated psychosis syndrome: A preliminary report.

Authors:  Assia Riccioni; Martina Siracusano; Michelangelo Vasta; Michele Ribolsi; Federico Fiori Nastro; Leonardo Emberti Gialloreti; Giorgio Di Lorenzo; Luigi Mazzone
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

5.  Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.

Authors:  Geor Bakker; Matthan W A Caan; Wilhelmina A M Vingerhoets; Fabiana da Silva-Alves; Mariken de Koning; Erik Boot; Dorien H Nieman; Lieuwe de Haan; Oswald J Bloemen; Jan Booij; Thérèse A M J van Amelsvoort
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

6.  EEG microstates as biomarker for psychosis in ultra-high-risk patients.

Authors:  Renate de Bock; Amatya J Mackintosh; Franziska Maier; Stefan Borgwardt; Anita Riecher-Rössler; Christina Andreou
Journal:  Transl Psychiatry       Date:  2020-08-24       Impact factor: 6.222

Review 7.  Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.

Authors:  I Bonoldi; O D Howes
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.